- Home
- About
- 🤖 AskAnzal AI Advisor
- 📅 Book a Call
- Your Account
- My AskAnzal Account
In-depth analysis of the grey areas, emerging risks, and practical lessons that matter to compliance leads, signatories, and medical affairs teams.
Dr Anzal Qurbain
19 Feb 2026 · 9 min read
AI tools can enhance Medical affairs MLR workflows but pose governance challenges. It’s crucial to implement strict controls, maintain compliance with the ABPI Code, and ensure documented human oversight.
TL;DR: Even a globally reputable company using trusted partners can stumble into serious compliance breaches online. All pharma…
What 214 Social Media cases taught me about compliance risk I’ve just finished reviewing 214 PMCPA cases where…
Ever wondered how something as innocent as a LinkedIn ‘like’ could pull an entire pharma company into PMCPA…
Let me take you behind the scenes of a Jazz Pharmaceuticals case that could have happened to any…
Every congress season, the influx of last-minute speaker decks exposes a familiar vulnerability in pharmaceutical communications. Speed, while…
Every spring and summer, the congress season breathes energy into the pharmaceutical world—a moment brimming with anticipation for…
A brand manager surprised me when she asked me if the new ad was ‘balanced’. I think she…
TL;DR: If your sponsorship declaration isn’t crystal-clear, up-front, and brutally honest about influence? It’s non-compliant. Tidy up your…
Ask one of 13 specialist ABPI advisors — instant answers, 24/7. No waiting, no gatekeeping.
12 modules. 12 weeks. Final Signatory readiness. The industry standard for ABPI Code signatories — £995 + VAT.
One real case. One key lesson. Every week — free.